Grade IV Glioma
Showing 1 - 25 of >10,000
Glioblastoma Multiforme Trial in Los Angeles, Cleveland (Perillyl alcohol)
Recruiting
- Glioblastoma Multiforme
- Perillyl alcohol
-
Los Angeles, California
- +1 more
Sep 23, 2022
Grade III or Grade IV Glioma Trial (PET imaging with 18F fluciclovine)
Not yet recruiting
- Grade III or Grade IV Glioma
- PET imaging with 18F fluciclovine
- (no location specified)
Jul 27, 2022
Glioblastoma, Glioma, Glioblastoma Multiforme Trial in Phoenix (AZD1390)
Recruiting
- Glioblastoma
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 10, 2022
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
High Grade Glioma, Glioblastoma Trial in Cleveland (Standard Surgical Treatment, Intraoperative Electrocorticography)
Not yet recruiting
- High Grade Glioma
- Glioblastoma
- Standard Surgical Treatment
- Intraoperative Electrocorticography
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Sep 30, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 2, 2023
Malignant Glioma, Glioblastoma Trial in Durham (hEGFRvIII-CD3 (BRiTE), Activated Cell Therapy)
Not yet recruiting
- Malignant Glioma
- Glioblastoma
- hEGFRvIII-CD3 (BRiTE)
- Activated Cell Therapy
-
Durham, North CarolinaDuke University Medical Center
Jun 24, 2022
Supramaximal Resection Versus Maximal Resection for High-Grade
Recruiting
- Glioblastoma
- +11 more
- Supramaximal resection
- Maximal safe resection
-
San Francisco, California
- +7 more
Nov 1, 2023
Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria
Suspended
- Glioblastoma
- Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
- +4 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an
Completed
- Glioma
- +7 more
- Neural stem cells loaded with an oncolytic adenovirus
-
Duarte, California
- +1 more
Dec 28, 2022
GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))
Completed
- GBM
- +3 more
- Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
-
Durham, North CarolinaDuke University Medical Center
Jun 28, 2022
Malignant Glioma Trial in United States (PVSRIPO)
Active, not recruiting
- Malignant Glioma
- PVSRIPO
-
San Francisco, California
- +5 more
Jun 28, 2022
High Grade Glioma Trial in Basel (endurance training, social support and counseling, resistance training)
Completed
- High Grade Glioma
- endurance training
- +2 more
-
Basel, Switzerland
- +1 more
May 17, 2022
Vascular Habitats Within Astrocytoma Grade 4 at Molecular,
Recruiting
- Astrocytoma, Grade IV
- +7 more
-
Valencia, SpainBiomedical Data Science Lab. Universitat Politècnica de València
May 11, 2022
Glioma, Glioblastoma Trial in Winston-Salem (Soliramfetol)
Recruiting
- Glioma
- Glioblastoma
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Jan 31, 2022
Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)
Active, not recruiting
- Glioblastoma
- +3 more
- Stereotactic Radiosurgery
-
Lake Success, New YorkNorthwell Health Brain Tumor Center
Feb 3, 2022
Intractable Epilepsy, Malignant Glioma, Seizure Disorder Trial in Jacksonville (Anticonvulsant Agent, Perampanel,
Recruiting
- Intractable Epilepsy
- +2 more
- Anticonvulsant Agent
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Nov 22, 2021
Malignant Glioma Trial in Durham (D2C7-IT (6920 ng/mL via convection-enhanced delivery), Atezolizumab (1200 mg every three
Recruiting
- Malignant Glioma
- D2C7-IT (6920 ng/mL via convection-enhanced delivery)
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Mar 22, 2022
Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Philadelphia (Intensity-Modulated Radiation Therapy,
Recruiting
- Glioblastoma
- +2 more
- Intensity-Modulated Radiation Therapy
- Quality-of-Life
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021
Grade II Glioma, Grade III Glioma, Grade IV Glioma Trial in Boston (Microdevice)
Recruiting
- Grade II Glioma
- +7 more
- Microdevice
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 22, 2021
Prospective Validation of Imaging Biomarkers Calculated at
Recruiting
- Astrocytoma, Grade IV
-
Valencia, SpainUniversitat Politècnica de València
Feb 7, 2022
Glioblastoma, High-grade Glioma Trial in Groningen (Cetuximab-IRDye800)
Recruiting
- Glioblastoma
- High-grade Glioma
-
Groningen, NetherlandsUMCG
Jun 26, 2023
Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
- +3 more
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 21, 2022
Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)
Recruiting
- Low-Grade Glioma
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 24, 2022